Late orbital recurrence of a choroidal melanoma following internal resection: Report of a case and review of the literature

Survey of Ophthalmology

Volumn 48, Issue 2, 2003, Pages 181-190

  Mittica, Nicholas ^a   Vemuganti, Geeta Kashyap ^b   Duffy, Mark ^a   Torczynski, Elise ^a   Edward, Deepak P ^a,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b L V PRASAD EYE INSTITUTE   (India)

^c Department of Ophthalmology ^*  (United States)

Author keywords

Choroid; Endoresection; Internal resection; Malignant melanoma; Orbit; Prognosis; Radiotherapy; Treatment

Indexed keywords

INTERLEUKIN 2;

BIOPSY; BRAIN; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CHOROID MELANOMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ENUCLEATION; EXOPHTHALMOS; FOLLOW UP; HISTOLOGY; HUMAN; HYPERTHERMIC THERAPY; IMMUNOTHERAPY; INTRAOCULAR PRESSURE; LASER COAGULATION; LENSECTOMY; LYMPHOKINE ACTIVATED KILLER CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; ORBIT; ORBIT TUMOR; PATHOLOGY; PRIORITY JOURNAL; RECURRENT CANCER; REVIEW; SCLERA BUCKLING PROCEDURE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VACCINATION; VISUAL ACUITY; VITRECTOMY;

EID: 0242417141     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(02)00458-7     Document Type: Review

References (91)

1. Collaborative Ocular Melanoma Study Group. Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. COMS report no. 6. Am J Ophthalmol 125:745-66, 1998.
2. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre- enucleation radiation of large choroidal melanoma II. initial mortality findings. COMS report no. 10 Am J Ophthalmol. 125:1998;779-796.
3. Collaborative Ocular Melanoma Study Group. Factors predictive of growth and treatment of small choroidal melanoma: COMS Report No. 5. The Collaborative Ocular Melanoma Study Group. Arch Ophthalmol 115:1537-44, 1997.
4. Affeldt J.C., Minckler D.S., Azen S.P., Yeh L. Prognosis in uveal melanoma with extrascleral extension. Arch Ophthalmol. 98:1980;1975-1979.
5. An K.P., Ratner D. Surgical management of cutaneous malignancies. Clin Dermatol. 19:2001;305-320.
6. Augsburger J.J., Gamel J.W., Lauritzen K., Brady L.W. Cobalt-60 plaque radiotherapy vs enucleation for posterior uveal melanoma. Am J Ophthalmol. 109:1990;585-592.
7. Augsburger J.J., Gamel J.W., Sardi V.F.et al. Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch Ophthalmol. 104:1986;655-661.
8. Augsburger J.J., Schroeder R.P., Territo C.et al. Clinical parameters predictive of enlargement of melanocytic choroidal lesions. Br J Ophthalmol. 73:1989;911-917.
9. Augusburger J.J., Gamel J.W., Shields J.A.et al. Post irradiation regression of choroidal melanoma as a risk factor for death from metastatic disease. Ophthalmology. 94:1988;1173-1177.
10. Bellmann C., Fuss M., Holz F.G.et al. Stereotactic radiation therapy for malignant choroidal tumors. preliminary, short-term results Ophthalmology. 107:2000;358-365.
11. Chang M., Zimmerman L.E., McLean I. The persisting pseudomelanoma problem. Arch Ophthalmol. 102:1984;726-727.
12. Char D.H. Metastatic choroidal melanoma. Am J Ophthalmol. 86:1978;76-80.
13. Char D.H., Castro J.R., Quivey J.M.et al. Helium ion charged particle therapy for choroidal melanoma. Ophthalmology. 87:1980;565-570.
14. Char D.H., Kroll S.M., Castro J. Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol. 125:1998;81-89.
15. Char D.H., Phillips T.L., Andejeski Y.et al. Failure of pre-enucleation radiation to decrease uveal melanoma mortality. Am J Ophthalmol. 106:1988;24-26.
16. Damato B., Groenewald C., McGalliard J.et al. Endoresection of choroidal melanoma. Br J Ophthalmol. 82:1998;213-218.
17. Damato B.E., Paul J., Foulds W.S. Risk factors for metastatic uveal melanoma after trans-scleral local resection. Br J Ophthalmol. 80:1996;109-116.
18. Diener-West M., Hawkins B.S., Markowitz J.A., Schachat A.P. A review of mortality from choroidal melanoma. II. A meta-analysis of. 5-(year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 110):1992;245-250.
19. Earle J., Kline R.W., Robertson D.M. Selection of iodine 125 for the Collaborative Ocular Melanoma Study. Arch Ophthalmol. 105:1987;763-764.
20. Egan K.M., Gragoudas E.S., Seddon J.M.et al. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology. 96:1989;1377-1382. discussion 1382-3.
21. Finger P.T. Radiation therapy for choroidal melanoma. Surv Ophthalmol. 42:1997;215-232.
22. Finger P.T., Packer S., Svitra P.P.et al. Hyperthermic treatment of intraocular tumors. Arch Ophthalmol. 102:1984;1477-1481.
23. Foulds W.S. Local resection and other conservative therapies for intraocular melanoma. Curr Opin Ophthalmol. 6:1995;62-69.
24. Foulds W.S., Damato B.E. Surgical resection of choroidal melanomas. Ryan S.J., Schachat A.P. Retina. 1989;713-720 CV Mosby, St. Louis.
25. Gamel J.W., McLean I.W. Computerized histopathologic assessment of malignant potential. II. A practical method for predicting survival following enucleation for uveal melanoma. Cancer. 52:1983;1032-1038.
26. Garcia-Arumi J., Sararols L., Martinez V., Corcostegui B. Vitreoretinal surgery and endoresection in high posterior choroidal melanomas. Retina. 21:2001;445-452.
27. Garretson B.R., Robertson D.M., Earle J.D. Choroidal melanoma treatment with iodine 125 brachytherapy. Arch Ophthalmol. 105:1987;1394-1397.
28. Gass J.D. Observation of suspected choroidal and ciliary body melanomas for evidence of growth prior to enucleation. Ophthalmology. 87:1980;523-528.
29. Gibbs P., Robinson W.A., Pearlman N.et al. Management of primary cutaneous melanoma of the head and neck. The University of Colorado experience and a review of the literature J Surg Oncol. 77:2001;179-185. discussion 186-7.
30. Goitein M., Miller T. Planning proton therapy of the eye. Med Phys. 10:1983;275-283.
31. Gragoudas E.S., Goitein M., Verhey L.et al. Proton beam irradiation. an alternative to enucleation for intraocular melanoma Ophthalmology. 87:1980;571-581.
32. Gragoudas E.S., Lane A.M., Regan S.et al. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 118:2000;773-778.
33. Gragoudas E.S., Seddon J.M., Egan K.M.et al. Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology. 95:1988;992-999.
34. Grossniklaus HE: Melanoma, in Ophthalmic Pathology and Intraocular Tumors, Section 4. Hong Kong: American Academy of Ophthalmology, 2000, pp 163-7,227,239-42.
35. Huang XQ, Mitchell MS, Liggett PE, et al: Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients. Cancer Immunol Immunother 38:399-405, 1994
36. Jensen O.A. Malignant melanomas of the human uvea. 25-year follow-up of cases in Denmark, 1943-1952 Acta Ophthalmol (Copenh). 60:1982;161-182.
37. Kan-Mitchell J., Liggett P.E., Harel W.et al. Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients. Cancer Immunol Immunother. 33:1991;333-340.
38. Keilholz U., Scheibenbogen C., Brado M.et al. Regional adoptive immunotherapy with interleukin-2 and lymphokine-activated killer (LAK) cells for liver metastases. Eur J Cancer. 30A:1994;103-105.
39. Kertes P.J., Johnson J.C., Peyman G.A. Internal resection of posterior uveal melanomas. Br J Ophthalmol. 82:1998;1147-1153.
40. Ksander B.R., Rubsamen P.E., Olsen K.R.et al. Studies of tumor-infiltrating lymphocytes from a human choroidal melanoma. Invest Ophthalmol Vis Sci. 32:1991;3198-3208.
41. Lee K.J., Peyman G.A., Raichand S. Internal eye wall resection for posterior uveal melanoma. Jpn J Ophthalmol. 37:1993;287-292.
42. Lommatzsch P. Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators. Surv Ophthalmol. 19:1974;85-100.
43. Lommatzsch P.K., Lommatzsch R. Treatment of juxtapapillary melanomas. Br J Ophthalmol. 75:1991;715-717.
44. Luyten G.P., Mooy C.M., Eijkenboom W.M.et al. No demonstrated effect of pre-enucleation irradiation on survival of patients with uveal melanoma. Am J Ophthalmol. 119:1995;786-791.
45. McLean I.W., Foster W.D., Zimmerman L.E., Martin D.G. Inferred natural history of uveal melanoma. Invest Ophthalmol Vis Sci. 19:1980;760-770.
46. McLean I.W., Zimmerman L.E., Evans R.M. Reappraisal of Callenders spindle a type of malignant melanoma of choroid and ciliary body. Am J Ophthalmol. 86:1978;557-564.
47. Meyer-Schwickerath G. The preservation of vision by treatment of intraocular tumor with light coagulation. Arch Ophthalmol. 66:1961;458-466.
48. Meyer-Schwickerath G. Further progress in the field of light coagulation. Trans Ophthalmol Soc UK. 77:1957;440.
49. Mitchell M.S., Liggett P.E., Green R.L.et al. Sustained regression of a primary choroidal melanoma under the influence of a therapeutic melanoma vaccine. J Clin Oncol. 12:1994;396-401.
50. Moore R.F. Choroidal sarcoma treated by the intraocular insertion of radon seeds. Br J Ophthalmol. 14:1930;145-156.
51. Munzenrider J.E., Gragoudas E.S., Seddon J.M.et al. Conservative treatment of uveal melanoma. probability of eye retention after proton treatment Int J Radiat Oncol Biol Phys. 15:1988;553-558.
52. Nathan P.D., Eisen T.G. The biological treatment of renal-cell carcinoma and melanoma. Lancet Oncol. 3:2002;89-96.
53. Niederkorn J.Y. Enucleation in consort with immunologic impairment promotes metastasis of intraocular melanomas in mice. Invest Ophthalmol Vis Sci. 25:1984;1080-1086.
54. Niederkorn J.Y. Enucleation-induced metastasis of intraocular melanomas in mice. Ophthalmology. 91:1984;692-700.
55. Oosterhuis J.A., Journee-de Korver H.G., Kakebeeke-Kemme H.M. Transpupillary thermotherapy in the management of choroidal melanoma. Arch Ophthalmol. 113:1995;315-321.
56. Packard R.B. Pattern of mortality in choroidal malignant melanoma. Br J Ophthalmol. 64:1980;565-575.
57. Peyman G.A., Barrada A. Retinochoroidectomy ab interno. Ophthalmic Surg. 15:1984;749-751.
58. Peyman G.A., Cohen S.B. Ab interno resection of uveal melanoma. Int Ophthalmol. 9:1986;29-36.
59. Peyman G.A., Gremillion C.M. Eye wall resection in the management of uveal neoplasms. Jpn J Ophthalmol. 33:1989;458-471.
60. Peyman G.A., Raichand M. Full-thickness eye wall resection of choroidal neoplasms. Ophthalmology. 86:1979;1024-1036.
61. Rand R.W., Khonsary A., Brown W.J.et al. Leksell stereotactic radiosurgery in the treatment of eye melanoma. Neurol Res. 9:1987;142-146.
62. Reintgen D., Cruse C.W., Atkins M. Cutaneous malignant melanoma. Clin Dermatol. 19:2001;253-261.
63. Robertson D.M. Melanoma endoresection. a perspective Retina. 21:2001;403-407.
64. Scotto J., Fraumeni J.F. Jr., Lee J.A. Melanomas of the eye and other noncutaneous sites. epidemiologic aspects J Natl Cancer Inst. 56:1976;489-491.
65. Seddon J.M., Albert D.M., Lavin P.T., Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol. 101:1983;1894-1899.
66. Seddon JM, Egan KM, Gragoudas ES: Choroidal melanoma: prognosis, in Ryan SJ (ed): Retina, Vol 1. St. Louis, CV Mosby, 1994, ed 2, pp 742-52.
67. Seddon JM, Egan KM, Gragoudas ES: Epidemiology of uveal melanoma, in Ryan SJ (ed): Retina, Vol 1. St. Louis, CV Mosby, 1994, ed 2, pp 717-72.
68. Seddon JM, Egan KM, Gragoudas ES: Epidemiology of uveal melanoma, in Ryan SJ (ed): Retina, Vol 1. St. Louis, CV Mosby, 1994, ed 2, pp 717-24.
69. Seddon J.M., Gragoudas E.S., Polivogianis L.et al. Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology. 93:1986;666-674.
70. Shammas H.F., Blodi F.C. Orbital extension of choroidal and ciliary body melanomas. Arch Ophthalmol. 95:1977;2002-2005.
71. Shammas H.F., Blodi F.C. Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol. 95:1977;63-69.
72. Shields C.L., Shields J.A. Transpupillary thermotherapy for choroidal melanoma. Curr Opin Ophthalmol. 10:1999;197-203.
73. Shields C.L., Shields J.A., Cater J.et al. Plaque radiotherapy for uveal melanoma. long-term visual outcome in 1106 consecutive patients Arch Ophthalmol. 118:2000;1219-1228.
74. Shields C.L., Shields J.A., Cater J.et al. Transpupillary thermotherapy for choroidal melanoma. tumor control and visual results in 100 consecutive cases Ophthalmology. 105:1998;581-590.
75. Shields C.L., Shields J.A., De Potter P.et al. Plaque radiotherapy for the management of uveal metastasis. Arch Ophthalmol. 115:1997;203-209.
76. Shields G.L., Shields J.A., Kiratli H.et al. Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmology. 102:1995;1351-1361.
77. Shields J.A., Augsburger J.J., Donoso L.A.et al. Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years. Am J Ophthalmol. 100:1985;666-668.
78. Shields J.A., Augusberger J.A., Corwin S. The management of uveal melanoma with extrascleral extension. Orbit. 6:1986;31-37.
79. Shields J.A., Glazer L.C., Mieler W.F.et al. Comparison of xenon arc and argon laser photocoagulation in the treatment of choroidal melanomas. Am J Ophthalmol. 109:1990;647-655.
80. Shields J.A., Shields C.L. Surgical approach to lamellar sclerouvectomy for posterior uveal melanomas. the 1986 Schoenberg lecture Ophthalmic Surg. 19:1988;774-780.
81. Shields JA, Shields CL: Management of posterior uveal melanoma, in Intraocular tumour: a text and atlas. Philadelphia, WB Saunders Co, 171-206,1992.
82. Shields JA, Shields CL, Shah P, DePotter P: Current alternatives in the management of posterior uvea melanomas. Trans Pa Acad Ophthalmol Otolaryngol 42:938-944, 1990
83. Stallard H.B. Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol. 50:1966;147-155.
84. Starr H.J., Zimmerman L.E. Extrascleral extension and orbital recurrence of malignant melanoma of the choroid and ciliary body. Int Ophthalmol Clin. 2:1962;369-384.
85. Straatsma B.R., Fine S.L., Earle J.D.et al. Enucleation versus plaque irradiation for choroidal melanoma. Ophthalmology. 95:1988;1000-1004.
86. Tallberg T., Uusitalo R., Sarna S.et al. Improvement of the recurrence-free interval using biological adjuvant therapy in uveal melanoma. Anticancer Res. 20:2000;1969-1975.
87. Vogel M.H. Treatment of malignant choroidal melanomas with photocoagulation. Evaluation of. 10-year(follow-up data. Am J Ophthalmol 74):1972;1-11.
88. Woodburn R., Danis R., Timmerman R. Preliminary experience in the treatment of choroidal melanoma with gamma knife radiosurgery. J Neurosurg. 93(Suppl):2000;177-179.
89. Zimmerman L.E., McLean I.W. Do growth and onset of symptoms of uveal melanomas indicate subclinical metastasis? Ophthalmology. 91:1984;685-691.
90. Zimmerman L.E., McLean I.W. An evaluation of enucleation in the management of uveal melanomas. Am J Ophthalmol. 87:1979;741-760.
91. Zimmerman L.E., McLean I.W., Foster W.D. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells. Br J Ophthalmol. 62:1978;420-425.